Cytek Biosciences, Inc.
CTKB
$5.36
-$0.03-0.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.78% | -5.48% | -1.66% | 5.89% | -3.56% |
| Total Receivables | 17.12% | 26.63% | 9.60% | 7.96% | -8.64% |
| Inventory | 10.78% | -0.36% | -16.90% | -28.06% | -30.52% |
| Prepaid Expenses | -9.38% | 43.84% | -5.15% | 16.30% | -13.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.80% | 10.47% | 11.67% | 11.68% | 74.59% |
| Total Current Assets | -0.44% | -0.33% | -2.10% | 1.12% | -7.61% |
|
|
|||||
| Total Current Assets | -0.44% | -0.33% | -2.10% | 1.12% | -7.61% |
| Net Property, Plant & Equipment | 2.00% | 26.59% | -1.75% | -3.86% | -1.67% |
| Long-term Investments | 3.18% | 3.24% | 3.06% | 2.97% | -1.66% |
| Goodwill | 3.18% | 3.24% | 3.06% | 2.97% | -1.66% |
| Total Other Intangibles | -13.74% | -13.16% | -12.68% | -12.81% | -15.64% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.87% | 12.29% | 4.25% | 7.86% | 33.06% |
| Total Assets | 0.75% | 1.98% | -1.92% | 1.02% | -5.43% |
|
|
|||||
| Total Accounts Payable | 41.62% | 114.76% | 67.70% | 82.35% | 14.39% |
| Total Accrued Expenses | 7.76% | 53.86% | 17.04% | 14.20% | 0.88% |
| Short-term Debt | -- | -- | 71.43% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 82.36% | 70.09% | 82.08% | 41.44% | 61.25% |
| Total Finance Division Other Current Liabilities | 10.88% | 16.56% | 11.11% | 2.69% | 3.76% |
| Total Other Current Liabilities | 10.88% | 16.56% | 11.11% | 2.69% | 3.76% |
| Total Current Liabilities | 19.76% | 39.88% | 21.82% | 20.34% | 6.99% |
|
|
|||||
| Total Current Liabilities | 19.76% | 39.88% | 21.82% | 20.34% | 6.99% |
| Long-Term Debt | -47.01% | -40.53% | -37.85% | -36.29% | -28.80% |
| Short-term Debt | -- | -- | 71.43% | -- | -- |
| Capital Leases | 73.98% | 74.03% | -14.36% | -20.33% | -23.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -20.55% | -15.85% | -20.16% | -19.22% | 1.91% |
| Total Liabilities | 10.01% | 22.37% | 3.54% | 2.34% | 1.79% |
|
|
|||||
| Common Stock & APIC | 1.21% | -1.22% | -0.62% | 1.75% | -4.78% |
| Retained Earnings | -28.60% | -13.99% | -31.84% | -20.64% | -29.29% |
| Treasury Stock & Other | 712.87% | 80.51% | 60.81% | 101.25% | 106.40% |
| Total Common Equity | -1.79% | -2.97% | -3.31% | 0.68% | -7.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.79% | -2.97% | -3.31% | 0.68% | -7.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.79% | -2.97% | -3.31% | 0.68% | -7.23% |
|
|
|||||